{
  "DOI": "10.1007/s10689-016-9879-3",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-016-9879-3",
  "alternative-id": [
    "9879"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Kruizinga",
      "given": "Roeliene C.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "van Marion",
      "given": "Denise M. S.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "den Dunnen",
      "given": "Wilfred F. A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Groot",
      "given": "Jan C.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hoving",
      "given": "Eelco W.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Oosting",
      "given": "Sjoukje F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Timmer-Bosscha",
      "given": "Hetty",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Derks",
      "given": "Rosalie P. H.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cornelissen",
      "given": "Chantal",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van der Luijt",
      "given": "Rob B.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Links",
      "given": "Thera P.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Vries",
      "given": "Elisabeth G. E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Walenkamp",
      "given": "Annemiek M. E.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        2,
        26
      ]
    ],
    "date-time": "2016-02-26T03:47:53Z",
    "timestamp": 1456458473000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        3,
        26
      ]
    ],
    "date-time": "2019-03-26T15:14:49Z",
    "timestamp": 1553613289000
  },
  "funder": [
    {
      "name": "Jan Kornelis de Cock Stichting"
    },
    {
      "name": "UEF-JSM Talent grant by the Van de Meer-Boerema foundation"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        27
      ]
    ],
    "date-time": "2024-03-27T04:35:58Z",
    "timestamp": 1711514158219
  },
  "is-referenced-by-count": 10,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2016,
        2,
        26
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2016,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            2,
            26
          ]
        ],
        "date-time": "2016-02-26T00:00:00Z",
        "timestamp": 1456444800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9879-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-016-9879-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9879-3",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "607-616",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2016,
        2,
        26
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        2,
        26
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/ejhg.2010.175",
      "author": "ER Maher",
      "doi-asserted-by": "crossref",
      "first-page": "617",
      "issue": "6",
      "journal-title": "Eur J Hum Genet",
      "key": "9879_CR1",
      "unstructured": "Maher ER, Neumann HP, Richard S (2011) von Hippel–Lindau disease: a clinical and scientific review. Eur J Hum Genet 19(6):617–623",
      "volume": "19",
      "year": "2011"
    },
    {
      "DOI": "10.1038/20459",
      "author": "PH Maxwell",
      "doi-asserted-by": "crossref",
      "first-page": "271",
      "issue": "6733",
      "journal-title": "Nature",
      "key": "9879_CR2",
      "unstructured": "Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271–275",
      "volume": "399",
      "year": "1999"
    },
    {
      "DOI": "10.1038/nrc1187",
      "author": "GL Semenza",
      "doi-asserted-by": "crossref",
      "first-page": "721",
      "issue": "10",
      "journal-title": "Nat Rev Cancer",
      "key": "9879_CR3",
      "unstructured": "Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721–732",
      "volume": "3",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nature01874",
      "author": "P Staller",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "issue": "6955",
      "journal-title": "Nature",
      "key": "9879_CR4",
      "unstructured": "Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W (2003) Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL. Nature 425(6955):307–311",
      "volume": "425",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nrc2442",
      "author": "G Bergers",
      "doi-asserted-by": "crossref",
      "first-page": "592",
      "issue": "8",
      "journal-title": "Nat Rev Cancer",
      "key": "9879_CR5",
      "unstructured": "Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8(8):592–603",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1038/leu.2008.299",
      "author": "JA Burger",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "issue": "1",
      "journal-title": "Leukemia",
      "key": "9879_CR6",
      "unstructured": "Burger JA, Peled A (2009) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 23(1):43–52",
      "volume": "23",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.cell.2005.02.034",
      "author": "A Orimo",
      "doi-asserted-by": "crossref",
      "first-page": "335",
      "issue": "3",
      "journal-title": "Cell",
      "key": "9879_CR7",
      "unstructured": "Orimo A, Gupta PB, Sgroi DC et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121(3):335–348",
      "volume": "121",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-04-4406",
      "author": "D Zagzag",
      "doi-asserted-by": "crossref",
      "first-page": "6178",
      "issue": "14",
      "journal-title": "Cancer Res",
      "key": "9879_CR8",
      "unstructured": "Zagzag D, Krishnamachary B, Yee H et al (2005) Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel–Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 65(14):6178–6188",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1182/blood-2008-05-158311",
      "author": "Z Zeng",
      "doi-asserted-by": "crossref",
      "first-page": "6215",
      "issue": "24",
      "journal-title": "Blood",
      "key": "9879_CR9",
      "unstructured": "Zeng Z, Shi YX, Samudio IJ et al (2009) Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood 113(24):6215–6224",
      "volume": "113",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1399-0004.2009.01281.x",
      "author": "ML Poulsen",
      "doi-asserted-by": "crossref",
      "first-page": "49",
      "issue": "1",
      "journal-title": "Clin Genet",
      "key": "9879_CR10",
      "unstructured": "Poulsen ML, Budtz-Jorgensen E, Bisgaard ML (2010) Surveillance in von Hippel–Lindau disease (vHL). Clin Genet 77(1):49–59",
      "volume": "77",
      "year": "2010"
    },
    {
      "DOI": "10.1097/GIM.0b013e3182091a1d",
      "author": "CR Lammens",
      "doi-asserted-by": "crossref",
      "first-page": "519",
      "issue": "6",
      "journal-title": "Genet Med",
      "key": "9879_CR11",
      "unstructured": "Lammens CR, Aaronson NK, Hes FJ et al (2011) Compliance with periodic surveillance for von-Hippel-Lindau disease. Genet Med 13(6):519–527",
      "volume": "13",
      "year": "2011"
    },
    {
      "author": "FJ Hes",
      "first-page": "505",
      "issue": "11",
      "journal-title": "Ned Tijdschr Geneeskd",
      "key": "9879_CR12",
      "unstructured": "Hes FJ, van der Luijt RB (2000) von Hippel–Lindau disease: protocols for diagnosis and periodical clinical monitoring. National von Hippel–Lindau disease working group. Ned Tijdschr Geneeskd 144(11):505–509",
      "volume": "144",
      "year": "2000"
    },
    {
      "key": "9879_CR13",
      "unstructured": "VHL Family Alliance (2012) The VHL handbook, what you need to know about VHL. 4th edn. CreateSpace Independent Publishing Platform, pp 46–51"
    },
    {
      "DOI": "10.1038/sj.leu.2403202",
      "author": "JJ Dongen van",
      "doi-asserted-by": "crossref",
      "first-page": "2257",
      "issue": "12",
      "journal-title": "Leukemia",
      "key": "9879_CR14",
      "unstructured": "van Dongen JJ, Langerak AW, Bruggemann M et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 17(12):2257–2317",
      "volume": "17",
      "year": "2003"
    },
    {
      "DOI": "10.1186/1476-4598-5-56",
      "author": "J Pan",
      "doi-asserted-by": "crossref",
      "first-page": "56",
      "journal-title": "Mol Cancer",
      "key": "9879_CR15",
      "unstructured": "Pan J, Mestas J, Burdick MD et al (2006) Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer 5:56",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.ophtha.2006.05.068",
      "author": "X Liang",
      "doi-asserted-by": "crossref",
      "first-page": "147",
      "issue": "1",
      "journal-title": "Ophthalmology",
      "key": "9879_CR16",
      "unstructured": "Liang X, Shen D, Huang Y et al (2007) Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel–Lindau disease. Ophthalmology 114(1):147–156",
      "volume": "114",
      "year": "2007"
    },
    {
      "DOI": "10.1097/01.iae.0000244659.62202.ee",
      "author": "CC Chan",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Retina",
      "key": "9879_CR17",
      "unstructured": "Chan CC, Collins AB, Chew EY (2007) Molecular pathology of eyes with von Hippel–Lindau (VHL) disease: a review. Retina 27(1):1–7",
      "volume": "27",
      "year": "2007"
    },
    {
      "DOI": "10.1177/153303460200100607",
      "author": "Y Song",
      "doi-asserted-by": "crossref",
      "first-page": "471",
      "issue": "6",
      "journal-title": "Technol Cancer Res Treat",
      "key": "9879_CR18",
      "unstructured": "Song Y, Constantinescu A, Mason RP (2002) Dynamic breast tumor oximetry: the development of prognostic radiology. Technol Cancer Res Treat 1(6):471–478",
      "volume": "1",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0360-3016(02)02822-5",
      "author": "D Zhao",
      "doi-asserted-by": "crossref",
      "first-page": "744",
      "issue": "3",
      "journal-title": "Int J Radiat Oncol Biol Phys",
      "key": "9879_CR19",
      "unstructured": "Zhao D, Constantinescu A, Hahn EW, Mason RP (2002) Differential oxygen dynamics in two diverse dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. Int J Radiat Oncol Biol Phys 53(3):744–756",
      "volume": "53",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jnnp.70.5.644",
      "author": "S Glasker",
      "doi-asserted-by": "crossref",
      "first-page": "644",
      "issue": "5",
      "journal-title": "J Neurol Neurosurg Psychiatry",
      "key": "9879_CR20",
      "unstructured": "Glasker S, Bender BU, Apel TW et al (2001) Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry 70(5):644–648",
      "volume": "70",
      "year": "2001"
    },
    {
      "DOI": "10.1371/journal.pgen.1002312",
      "author": "LE Moore",
      "doi-asserted-by": "crossref",
      "first-page": "e1002312",
      "issue": "10",
      "journal-title": "PLoS Genet",
      "key": "9879_CR21",
      "unstructured": "Moore LE, Nickerson ML, Brennan P et al (2011) von Hippel–Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors. PLoS Genet 7(10):e1002312",
      "volume": "7",
      "year": "2011"
    },
    {
      "DOI": "10.3171/jns.2002.97.4.0977",
      "author": "JM Gijtenbeek",
      "doi-asserted-by": "crossref",
      "first-page": "977",
      "issue": "4",
      "journal-title": "J Neurosurg",
      "key": "9879_CR22",
      "unstructured": "Gijtenbeek JM, Jacobs B, Sprenger SH et al (2002) Analysis of von Hippel–Lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity. J Neurosurg 97(4):977–982",
      "volume": "97",
      "year": "2002"
    },
    {
      "author": "H Kanno",
      "first-page": "4845",
      "issue": "18",
      "journal-title": "Cancer Res",
      "key": "9879_CR23",
      "unstructured": "Kanno H, Kondo K, Ito S et al (1994) Somatic mutations of the von Hippel–Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54(18):4845–4847",
      "volume": "54",
      "year": "1994"
    },
    {
      "author": "JY Lee",
      "first-page": "504",
      "issue": "3",
      "journal-title": "Cancer Res",
      "key": "9879_CR24",
      "unstructured": "Lee JY, Dong SM, Park WS et al (1998) Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 58(3):504–508",
      "volume": "58",
      "year": "1998"
    },
    {
      "DOI": "10.1093/jnen/63.10.1072",
      "author": "S Lemeta",
      "doi-asserted-by": "crossref",
      "first-page": "1072",
      "issue": "10",
      "journal-title": "J Neuropathol Exp Neurol",
      "key": "9879_CR25",
      "unstructured": "Lemeta S, Pylkkanen L, Sainio M et al (2004) Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas. J Neuropathol Exp Neurol 63(10):1072–1079",
      "volume": "63",
      "year": "2004"
    },
    {
      "DOI": "10.1002/(SICI)1096-9896(199606)179:2\u003c151::AID-PATH556\u003e3.0.CO;2-0",
      "author": "J Oberstrass",
      "doi-asserted-by": "crossref",
      "first-page": "151",
      "issue": "2",
      "journal-title": "J Pathol",
      "key": "9879_CR26",
      "unstructured": "Oberstrass J, Reifenberger G, Reifenberger J, Wechsler W, Collins VP (1996) Mutation of the von Hippel–Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system. J Pathol 179(2):151–156",
      "volume": "179",
      "year": "1996"
    },
    {
      "DOI": "10.1093/ajcp/107.4.459",
      "author": "JY Tse",
      "doi-asserted-by": "crossref",
      "first-page": "459",
      "issue": "4",
      "journal-title": "Am J Clin Pathol",
      "key": "9879_CR27",
      "unstructured": "Tse JY, Wong JH, Lo KW, Poon WS, Huang DP, Ng HK (1997) Molecular genetic analysis of the von Hippel–Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas. Am J Clin Pathol 107(4):459–466",
      "volume": "107",
      "year": "1997"
    },
    {
      "DOI": "10.1002/(SICI)1096-9098(199810)69:2\u003c99::AID-JSO10\u003e3.0.CO;2-M",
      "author": "A Sehgal",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "issue": "2",
      "journal-title": "J Surg Oncol",
      "key": "9879_CR28",
      "unstructured": "Sehgal A, Keener C, Boynton AL, Warrick J, Murphy GP (1998) CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol 69(2):99–104",
      "volume": "69",
      "year": "1998"
    },
    {
      "DOI": "10.1038/35065016",
      "author": "A Muller",
      "doi-asserted-by": "crossref",
      "first-page": "50",
      "issue": "6824",
      "journal-title": "Nature",
      "key": "9879_CR29",
      "unstructured": "Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50–56",
      "volume": "410",
      "year": "2001"
    },
    {
      "author": "SA Rempel",
      "first-page": "102",
      "issue": "1",
      "journal-title": "Clin Cancer Res",
      "key": "9879_CR30",
      "unstructured": "Rempel SA, Dudas S, Ge S, Gutierrez JA (2000) Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6(1):102–111",
      "volume": "6",
      "year": "2000"
    },
    {
      "DOI": "10.1172/JCI40283",
      "author": "M Kioi",
      "doi-asserted-by": "crossref",
      "first-page": "694",
      "issue": "3",
      "journal-title": "J Clin Invest",
      "key": "9879_CR31",
      "unstructured": "Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM (2010) Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 120(3):694–705",
      "volume": "120",
      "year": "2010"
    },
    {
      "DOI": "10.1002/ijc.25665",
      "author": "S Hassan",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "issue": "1",
      "journal-title": "Int J Cancer",
      "key": "9879_CR32",
      "unstructured": "Hassan S, Buchanan M, Jahan K et al (2011) CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. Int J Cancer 129(1):225–232",
      "volume": "129",
      "year": "2011"
    },
    {
      "author": "RS Taichman",
      "first-page": "1832",
      "issue": "6",
      "journal-title": "Cancer Res",
      "key": "9879_CR33",
      "unstructured": "Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK (2002) Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62(6):1832–1837",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-07-0899",
      "author": "V Falco De",
      "doi-asserted-by": "crossref",
      "first-page": "11821",
      "issue": "24",
      "journal-title": "Cancer Res",
      "key": "9879_CR34",
      "unstructured": "De Falco V, Guarino V, Avilla E et al (2007) Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. Cancer Res 67(24):11821–11829",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.bjc.6604745",
      "author": "Z Wang",
      "doi-asserted-by": "crossref",
      "first-page": "1695",
      "issue": "10",
      "journal-title": "Br J Cancer",
      "key": "9879_CR35",
      "unstructured": "Wang Z, Ma Q, Liu Q et al (2008) Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical wnt pathway. Br J Cancer 99(10):1695–1703",
      "volume": "99",
      "year": "2008"
    },
    {
      "DOI": "10.2353/ajpath.2009.080636",
      "author": "RA Bartolome",
      "doi-asserted-by": "crossref",
      "first-page": "602",
      "issue": "2",
      "journal-title": "Am J Pathol",
      "key": "9879_CR36",
      "unstructured": "Bartolome RA, Ferreiro S, Miquilena-Colina ME et al (2009) The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. Am J Pathol 174(2):602–612",
      "volume": "174",
      "year": "2009"
    },
    {
      "author": "IS Zeelenberg",
      "first-page": "3833",
      "issue": "13",
      "journal-title": "Cancer Res",
      "key": "9879_CR37",
      "unstructured": "Zeelenberg IS, Ruuls-Van Stalle L, Roos E (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63(13):3833–3839",
      "volume": "63",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s10585-007-9133-3",
      "author": "SY Kim",
      "doi-asserted-by": "crossref",
      "first-page": "201",
      "issue": "3",
      "journal-title": "Clin Exp Metastasis",
      "key": "9879_CR38",
      "unstructured": "Kim SY, Lee CH, Midura BV et al (2008) Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25(3):201–211",
      "volume": "25",
      "year": "2008"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-04-1844",
      "author": "MC Smith",
      "doi-asserted-by": "crossref",
      "first-page": "8604",
      "issue": "23",
      "journal-title": "Cancer Res",
      "key": "9879_CR39",
      "unstructured": "Smith MC, Luker KE, Garbow JR et al (2004) CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64(23):8604–8612",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.jss.2008.06.044",
      "author": "EH Huang",
      "doi-asserted-by": "crossref",
      "first-page": "231",
      "issue": "2",
      "journal-title": "J Surg Res",
      "key": "9879_CR40",
      "unstructured": "Huang EH, Singh B, Cristofanilli M et al (2009) A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer. J Surg Res 155(2):231–236",
      "volume": "155",
      "year": "2009"
    },
    {
      "DOI": "10.1002/pros.21008",
      "author": "S Porvasnik",
      "doi-asserted-by": "crossref",
      "first-page": "1460",
      "issue": "13",
      "journal-title": "Prostate",
      "key": "9879_CR41",
      "unstructured": "Porvasnik S, Sakamoto N, Kusmartsev S et al (2009) Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth. Prostate 69(13):1460–1469",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.bjc.6603251",
      "author": "CC Schimanski",
      "doi-asserted-by": "crossref",
      "first-page": "210",
      "issue": "2",
      "journal-title": "Br J Cancer",
      "key": "9879_CR42",
      "unstructured": "Schimanski CC, Bahre R, Gockel I et al (2006) Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer 95(2):210–217",
      "volume": "95",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nrd2819",
      "author": "JF DiPersio",
      "doi-asserted-by": "crossref",
      "first-page": "105",
      "issue": "2",
      "journal-title": "Nat Rev Drug Discov",
      "key": "9879_CR43",
      "unstructured": "DiPersio JF, Uy GL, Yasothan U, Kirkpatrick P (2009) Plerixafor. Nat Rev Drug Discov 8(2):105–106",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ejca.2012.05.005",
      "author": "UM Domanska",
      "doi-asserted-by": "crossref",
      "first-page": "219",
      "issue": "1",
      "journal-title": "Eur J Cancer",
      "key": "9879_CR44",
      "unstructured": "Domanska UM, Kruizinga RC, Nagengast WB et al (2013) A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur J Cancer 49(1):219–230",
      "volume": "49",
      "year": "2013"
    },
    {
      "DOI": "10.3109/13816819509059966",
      "author": "ER Maher",
      "doi-asserted-by": "crossref",
      "first-page": "79",
      "issue": "3",
      "journal-title": "Ophthalmic Genet",
      "key": "9879_CR45",
      "unstructured": "Maher ER, Webster AR, Moore AT (1995) Clinical features and molecular genetics of von Hippel–Lindau disease. Ophthalmic Genet 16(3):79–84",
      "volume": "16",
      "year": "1995"
    },
    {
      "DOI": "10.1046/j.1365-2796.1998.00337.x",
      "author": "S Richard",
      "doi-asserted-by": "crossref",
      "first-page": "547",
      "issue": "6",
      "journal-title": "J Intern Med",
      "key": "9879_CR46",
      "unstructured": "Richard S, Campello C, Taillandier L, Parker F, Resche F (1998) Haemangioblastoma of the central nervous system in von Hippel–Lindau disease. French VHL study group. J Intern Med 243(6):547–553",
      "volume": "243",
      "year": "1998"
    },
    {
      "author": "A Slater",
      "first-page": "1570",
      "issue": "8",
      "journal-title": "AJNR Am J Neuroradiol",
      "key": "9879_CR47",
      "unstructured": "Slater A, Moore NR, Huson SM (2003) The natural history of cerebellar hemangioblastomas in von Hippel–Lindau disease. AJNR Am J Neuroradiol 24(8):1570–1574",
      "volume": "24",
      "year": "2003"
    },
    {
      "DOI": "10.1001/jama.1995.03520310062031",
      "author": "WM Linehan",
      "doi-asserted-by": "crossref",
      "first-page": "564",
      "issue": "7",
      "journal-title": "JAMA",
      "key": "9879_CR48",
      "unstructured": "Linehan WM, Lerman MI, Zbar B (1995) Identification of the von Hippel–Lindau (VHL) gene: its role in renal cancer. JAMA 273(7):564–570",
      "volume": "273",
      "year": "1995"
    },
    {
      "DOI": "10.1016/S0140-6736(03)13643-4",
      "author": "RR Lonser",
      "doi-asserted-by": "crossref",
      "first-page": "2059",
      "issue": "9374",
      "journal-title": "Lancet",
      "key": "9879_CR49",
      "unstructured": "Lonser RR, Glenn GM, Walther M et al (2003) von Hippel–Lindau disease. Lancet 361(9374):2059–2067",
      "volume": "361",
      "year": "2003"
    },
    {
      "DOI": "10.1371/journal.pone.0051780",
      "author": "L Amit",
      "doi-asserted-by": "crossref",
      "first-page": "e51780",
      "issue": "1",
      "journal-title": "PLoS ONE",
      "key": "9879_CR50",
      "unstructured": "Amit L, Ben-Aharon I, Vidal L, Leibovici L, Stemmer S (2013) The impact of bevacizumab (avastin) on survival in metastatic solid tumors—a meta-analysis and systematic review. PLoS ONE 8(1):e51780",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ccr.2008.01.034",
      "author": "R Du",
      "doi-asserted-by": "crossref",
      "first-page": "206",
      "issue": "3",
      "journal-title": "Cancer Cell",
      "key": "9879_CR51",
      "unstructured": "Du R, Lu KV, Petritsch C et al (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13(3):206–220",
      "volume": "13",
      "year": "2008"
    },
    {
      "DOI": "10.1002/path.2908",
      "author": "YF Ping",
      "doi-asserted-by": "crossref",
      "first-page": "344",
      "issue": "3",
      "journal-title": "J Pathol",
      "key": "9879_CR52",
      "unstructured": "Ping YF, Yao XH, Jiang JY et al (2011) The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J Pathol 224(3):344–354",
      "volume": "224",
      "year": "2011"
    }
  ],
  "reference-count": 52,
  "references-count": 52,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-016-9879-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}